• U3 snoRNA and DDX21 Interdependence in Mitotic Regulation

  2026-05-22

  A recent study reveals that U3 snoRNA and the RNA helicase DDX21 colocalize and inter-regulate within the perichromosomal region (PR) to control mitotic progression. The findings highlight a phase separation-mediated mechanism and suggest that balanced U3-DDX21 interactions are essential for proper mitosis, with practical implications for RNA-protein interaction research.

• Tamsulosin in Urological Research: Applied Workflows & Troub

  2026-05-21

  Tamsulosin, a selective α₁A-adrenergic receptor antagonist, is revolutionizing smooth muscle and urological disease research with robust assay performance and reproducible results. This article unpacks experimental workflows, protocol parameters, and troubleshooting strategies, leveraging APExBIO’s Tamsulosin for maximum translational impact.

• Meropenem: Optimizing β-Lactam Antibiotic Carbapenem Assays

  2026-05-21

  Meropenem stands out as an ultra-broad-spectrum β-lactam antibiotic carbapenem, enabling highly reproducible modeling of Gram-negative and Gram-positive infections, including resistant strains. This article delivers actionable workflows, troubleshooting tools, and performance comparisons to elevate your antimicrobial research.

• XPO1 Inhibition by Eltanexor Modulates Wnt/β-catenin in CRC

  2026-05-20

  This study demonstrates that Eltanexor (KPT-8602) suppresses colorectal cancer tumorigenesis by inhibiting XPO1-mediated nuclear export, with a specific impact on the Wnt/β-catenin pathway and COX-2 expression. These mechanistic insights strengthen the rationale for targeting XPO1 in colorectal cancer chemoprevention and lay groundwork for further translational research.

• SM-102: Molecular Optimization in mRNA Vaccine Lipid Deliver

  2026-05-20

  Explore the molecular and computational advancements of SM-102, a key lipid for mRNA delivery systems. This article delves into its precise mechanistic role and how machine learning is reshaping lipid nanoparticle formulation for next-gen mRNA therapeutics.

• Capsaicin (SKU C6366): Reliable Solutions for TRPV1 & KDM1A

  2026-05-19

  This article delivers scenario-driven, evidence-based guidance for researchers using Capsaicin (SKU C6366) in cell viability, proliferation, and cytotoxicity workflows. By addressing common laboratory challenges and comparing product quality and mechanistic specificity, it equips scientists to leverage Capsaicin’s TRPV1 ion channel activation and KDM1A/LSD1 inhibition properties for reproducible, quantitative results.

• NLRP3 Inflammasome's Role in Coagulation During Endotoxemia

  2026-05-19

  This study delineates the distinct contributions of TLR4, caspase-11, and the NLRP3 inflammasome to the release of tissue factor-positive extracellular vesicles and coagulation activation in endotoxemic mice. The findings refine our mechanistic understanding of inflammatory and coagulation pathways in sepsis models, clarifying the relative impact of these signaling nodes for translational inflammatory disease research.

• Dinaciclib (SCH727965): CDK Inhibitor for Cancer and Cell Cy

  2026-05-18

  Dinaciclib (SCH727965) is a potent cyclin-dependent kinase inhibitor that induces apoptosis and cell cycle arrest in cancer models. Its multi-target mechanism disrupts key regulatory pathways, making it valuable for oncology research. APExBIO provides validated product A8412 for reproducible investigations.

• IRF4-Mediated B Cell Activation via CD40/STING in ESCC TLS

  2026-05-18

  This study elucidates how competitive binding between CD40 and STING with TRAF2 drives IRF4-mediated B cell activation within tertiary lymphoid structures (TLS) in esophageal squamous cell carcinoma (ESCC). The findings reveal vital mechanisms underpinning adaptive immunity and highlight targets for future biomarker and therapeutic development.

• Co-Targeting BRD4 and RAC1 Disrupts Oncogenic Axes in Breast

  2026-05-17

  This study demonstrates that combined inhibition of BET bromodomain protein BRD4 and RAC1 suppresses growth, stemness, and tumorigenesis across breast cancer subtypes by disrupting the c-MYC-G9a-FTH1 regulatory axis and downregulating HDAC1. These findings highlight mechanistic vulnerabilities in cancer epigenetics, suggesting new combinatorial strategies for targeting tumor progression.

• Rifampin in Translational Research: Mechanism to Application

  2026-05-16

  This thought-leadership article by APExBIO unpacks the mechanistic foundation and strategic application of Rifampin, a rifamycin antibiotic, as a gold-standard tool for bacterial resistance mechanism research and synthetic biology transcription inhibition. By integrating protocol parameters, evidence from recent literature, and a comparative lens on the evolving translational landscape, the article provides actionable guidance for researchers seeking to maximize the translational potential of Rifampin in complex experimental systems.

• E-64: Precision Cysteine Protease Inhibition in Cancer Resea

  2026-05-15

  E-64, a potent L-trans-epoxysuccinyl peptide inhibitor, enables robust and selective cysteine protease inhibition for mechanistic studies and workflow reproducibility. Its application in cancer immunology and protein turnover research is underpinned by nanomolar efficacy and irreversibility, making it a gold-standard tool for dissecting cathepsin function and immune modulation.

• Iron Stress Reprograms Enterocyte Metabolism and Inflammator

  2026-05-15

  Navazesh and Ji's 2025 study reveals that both iron deficiency and iron excess distinctly reprogram enterocyte metabolism and modulate inflammatory gene expression in IPEC-J2 cells. These findings elucidate the molecular basis of iron-driven intestinal pathophysiology, providing a foundation for future research into iron-dependent cellular mechanisms.

• HBsAg Suppresses Interferon and Triggers Autophagy via TBK1

  2026-05-14

  This study reveals how hepatitis B surface antigen (HBsAg) manipulates TANK-binding kinase 1 (TBK1), disrupting host innate immunity by suppressing type I interferon and inducing early autophagy. These mechanistic insights improve our understanding of HBV immune evasion and may inform future approaches to chronic hepatitis B intervention.

• Applied Use of MCC950 Sodium in NLRP3 Inflammasome Assays

  2026-05-14

  MCC950 sodium (CRID3 sodium salt) enables highly selective and potent inhibition of the NLRP3 inflammasome in both murine and human macrophage models. This article details optimized experimental workflows, stepwise troubleshooting, and strategic insights from recent research, empowering inflammatory and autoimmune disease modelers to achieve consistent and interpretable results.

446 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page